We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$484M
AUM Growth
+$61.6M
Cap. Flow
+$48.7M
Cap. Flow %
10.05%
Top 10 Hldgs %
47.59%
Holding
66
New
18
Increased
20
Reduced
8
Closed
19

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$14.8M
2
VNDA icon
Vanda Pharmaceuticals
VNDA
+$14.7M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$13.7M
4
FTD
FTD Companies, Inc. Common Stock
FTD
+$11.4M
5
VSTO
Vista Outdoor Inc.
VSTO
+$11.1M

Top Sells

Rank Stock Value
1
PCRX icon
Pacira BioSciences
PCRX
+$12.9M
2
LVS icon
Las Vegas Sands
LVS
+$12.6M
3
CPB icon
Campbell Soup
CPB
+$9.55M
4
WFM
Whole Foods Market Inc
WFM
+$9.39M
5
URBN icon
Urban Outfitters
URBN
+$8.54M

Sector Composition

Rank Sector Weight
1 Healthcare 37.37%
2 Consumer Discretionary 21.51%
3 Consumer Staples 10.76%
4 Industrials 3.99%
5 Financials 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
26
DELISTED
Strongbridge Biopharma plc.
SBBP
$7.79M 1.61%
+1,640,000
New +$5.02M
LOCO icon
27
El Pollo Loco
LOCO
$488M
$7.77M 1.6%
650,000
+266,000
+69% +$3.26M
BBY icon
28
Best Buy
BBY
$18.6B
$7.37M 1.52%
+150,000
New +$6.7M
AET
29
DELISTED
Aetna Inc
AET
$6.38M 1.32%
50,000
-14,000
-22% -$1.76M
ALIM
30
DELISTED
Alimera Sciences
ALIM
$6.21M 1.28%
295,733
+82,400
+39% +$1.59M
DECK icon
31
CALL
Deckers Outdoor
DECK
$13.7B
$5.97M 1.23%
+600,000
New +$5.54M
ANF icon
32
Abercrombie & Fitch
ANF
$4.34B
$5.37M 1.11%
+450,000
New +$5.36M
ABUS icon
33
Arbutus Biopharma
ABUS
$871M
$5.2M 1.07%
1,600,000
-340,000
-18% -$943K
DKS icon
34
Dick's Sporting Goods
DKS
$18.3B
$4.87M 1%
+100,000
New +$5.07M
DFRG
35
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$4.33M 0.89%
240,000
+128,000
+114% +$2.19M
TLRD
36
DELISTED
Tailored Brands, Inc.
TLRD
$4.3M 0.89%
288,000
-12,000
-4% -$242K
AVEO
37
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.83M 0.58%
+480,000
New +$3.47M
WSM icon
38
Williams-Sonoma
WSM
$27.2B
$2.79M 0.58%
+104,000
New +$2.53M
TLRD
39
CALL
DELISTED
Tailored Brands, Inc.
TLRD
$2.39M 0.49%
+160,000
New +$3.22M
BLUE
40
DELISTED
bluebird bio
BLUE
$2.18M 0.45%
1,853
-1,235
-40% -$1.26M
MDGL icon
41
Madrigal Pharmaceuticals
MDGL
$12.8B
$1.97M 0.41%
128,000
+4,000
+3% +$62.9K
ARLZ
42
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$1.5M 0.31%
700,000
-2,136,000
-75% -$8.03M
DYNT
43
DELISTED
Dynatronics Corp
DYNT
$1.43M 0.29%
+100,000
New +$1.36M
ATEC icon
44
Alphatec Holdings
ATEC
$1.35B
$1.26M 0.26%
+542,414
New +$1.73M
PDLI
45
DELISTED
PDL BioPharma, Inc.
PDLI
$1.14M 0.23%
+500,000
New +$1.11M
LRMR icon
46
Larimar Therapeutics
LRMR
$399M
$522K 0.11%
+9,333
New +$463K
AEO icon
47
American Eagle Outfitters
AEO
$2.92B
– –
-524,000
Closed -$7.95M
BJRI icon
48
BJ's Restaurants
BJRI
$1.42B
– –
-88,000
Closed -$3.46M
CPB icon
49
Campbell Soup
CPB
$6.72B
– –
-158,000
Closed -$9.55M
DLTR icon
50
Dollar Tree
DLTR
$23.9B
– –
-50,000
Closed -$3.86M
1
2
3

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q1 2017 Portfolio in Review

As of Q1 2017, Armistice Capital held 66 positions worth $484M, up 15% from $423M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Armistice Capital deployed $48.7M of net new capital in Q1 2017, opening 18 new positions and adding to 20 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 40,000 shares worth $15.5M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Aralez Pharmaceuticals Inc., an estimated $8.03M trimmed.

  • Armistice Capital's largest Q1 2017 buy was Regeneron Pharmaceuticals: 40,000 shares worth $15.5M.
  • Armistice Capital added most to Vanda Pharmaceuticals in Q1 2017, an estimated $14.7M increase.
  • Armistice Capital's biggest Q1 2017 reduction was Aralez Pharmaceuticals Inc., cutting an estimated $8.03M.
  • Armistice Capital fully exited Pacira BioSciences in Q1 2017, selling an estimated $12.9M.
  • Armistice Capital's ten largest holdings make up 48% of its $484M portfolio in Q1 2017.
  • Armistice Capital opened 18 new positions and closed 19 in Q1 2017.
  • Armistice Capital's portfolio value rose 15% quarter-over-quarter to $484M.

Based on Armistice Capital's 13F filing for Q1 2017, filed 15 May 2017.